FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Novo’s Ozempic, Wegovy Shortage Ends, Threatening Copycats
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
Trump live: MAGA crowd chants for 2028 run; Musk waves chainsaw around in bizarre CPAC appearance
President hailed at White House Black History Month event – and from stage at conservative conference by former adviser Steve Bannon – with calls to run again in 2028 in defiance of the Constitution ...
U.S. attorneys general forum urges FDA to act against counterfeit weight loss drugs
U.S. attorneys general urge the FDA to combat counterfeit versions of weight loss drugs developed by Eli Lilly (LLY) and Novo ...
TASS7h
Hungary, Russia coordinate to supply gas to Transnistria — Szijjarto
The Hungarian foreign minister "consulted with a Hungarian-owned energy company, as well as with the Minister of Foreign Affairs of the Republic of Moldova" ...
Florida sues Target over LGBTQ Pride campaign that sparked consumer backlash, stock drop
Florida Attorney General James Uthmeier announced a class-action lawsuit against Target Corp. over a 2023 LGBTQ Pride ...
GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine ...
Florida gets revenge on Target over tuck swimsuits and DEI obsession that sparked a culture war
Newly-appointed Florida Attorney General James Uthmeier has taken aim at Target for its disastrous 2023 Pride campaign, which ...